Physician profile
Mark Grossman
NPI 1063402014
$14,779.66
in general payments reported to CMS, 2019-2025
19 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,088 · 2020: $1,524 · 2021: $310 · 2022: $6,511 · 2023: $1,035 · 2024: $2,185 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,997 · Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,997.07 |
| Food and Beverage | $1,350.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $5,942.08 | 2019-2022 | |
| Arthrex, INC. | $3,217.38 | 2022-2024 | |
| Polaris Technology Solutions LLC | $1,539.87 | 2022-2025 | |
| Exactech, INC. | $1,296.76 | 2022 | |
| Medical Device Business Services, INC. | $937.40 | 2020-2024 | Inhance |
| Ferring Pharmaceuticals INC. | $550.93 | 2019-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $296.92 | 2019 | |
| Miach Orthopaedics, INC. | $245.55 | 2024 | |
| Depuy Synthes Sales INC. | $222.95 | 2020-2022 | |
| Horizon Therapeutics Plc | $139.17 | 2019-2022 | |
| Lifenet Health | $122.68 | 2022 | |
| Heron Therapeutics, INC. | $106.71 | 2025 | Zynrelef |
| Vericel Corporation | $44.20 | 2022-2024 | Maci |
| Baxter Healthcare | $25.84 | 2019 | |
| Smith+Nephew, INC. | $22.25 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $20.86 | 2020 | |
| Medartis INC. | $17.88 | 2021 | |
| Bioventus LLC | $17.67 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.